Israel Glucometer Market Competition, Forecast and Opportunities, 2028

Glucometer is a medical device that determines the approximate concentration of glucose in the blood. It typically uses a drop of blood which is placed on a disposable test strip where its chemical reaction with glucose changes the electrical conductivity of the strip. Some of the characteristics which defines the excellency of a glucometer includes small size, computer downloading capabilities, extended memory capacity and blood glucose manipulation techniques. True Metrix Self-Monitoring Glucose System is known to be the best glucometer used across the world because of its quick and accurate blood glucose testing. In the growing field of medical devices, Israel is ranked at second position with a total of thousand companies manufacturing a huge number of medical devices every year. In the recent years, there has been a recognizable increase in prevalence of various chronic diseases among population of Israel especially cancer, cardiac disorders, and diabetes. Among all these diseases, there is no permanent cure for diabetes. However, with treatment the condition can be managed, and it is possible to reach a stage of diabetes remission. Several devices that can assist patients to manage their diabetes comprises of ketone monitor, blood glucose monitor, continuous glucose monitor, insulin pumps, smart insulin pens, and diabetes management applications. Increase in number of treatment procedures carried out in the country due to rise in diabetes instances is leading to rise in purchase of glucometers which is expected to boost the growth of Israel glucometer market in upcoming years. Moreover, high obesity rate among people of the country, which is one of the major risk factors related to diabetes, can also propel the growth of glucometer market in Israel. Growing technological advancements associated with improvement in healthcare facilities of the country is also expected to bolster the growth of glucometer market in Israel. Henceforth, growth in geriatric population of the country is also expected to propel the growth of market in coming years due to their increasing chances of getting affected with various kinds of diseases.

Growing Prevalence of Chronic Diseases

Chronic disease can be defined as a long-term health condition that persist over a prolonged period and may require ongoing medical attention or management. These diseases are typically non-communicable diseases and are caused by a combination of genetic, environmental, and lifestyle factors. Some of the commonly prevailing diseases among the people of Israel comprises of cancer, cardiac disorders, and diabetes. As per Israel Diabetes Market Report 2023, Type 1 diabetes holds minimum percentages among Israelis than Type 2 diabetes mellitus. Some of the common risk factors which lead to the development of diabetes in a human body comprises of intake of unhealthy diet, physical inactivity, consumption of alcohol, smoking cigarettes, and others. According to the data published by National Library of Medicine in 2019, it has been reported that out of the total sample population, 13.7% were found to be affected with Type 2 Diabetes Mellitus (T2DM). The prevalence of T2DM increased sharply over successive age groups in both men and women. The prevalence of type 2 diabetes has been found to increase gradually with increasing BMI, especially in women (~20%, 37%, and 44%, respectively), while, in men it increased sharply (from 25% to ~50%) until a BMI of 29.9; it then decreased drastically (to ~24%) for a BMI of ≥30. Approximately 85% of men with type 2 diabetes were physically inactive, while her 97% of women with type 2 diabetes were physically inactive. According to Food and Drug Administration (FDA), it has been observed that accurate glucometers provide result within 15% of the lab reading. The evident increase in prevalence of diabetes among Israelis is leading to the rise in demand of glucometers by patients which is expected to propel the growth of Israel Glucometer market in the forecast period.

Technological Advancements

Increasing prevalence of diabetes in Israel is leading to various technological advancements in the healthcare system of the country. Combo Glucometer (CoG) is the first non-invasive product which has been made commercial in the country that can be used for glucose monitoring. While using Combo Glucometer, the user only needs to place a finger in the device, which assesses reflected light from tissue via a digital image sensor and then employs proprietary algorithms to measure blood glucose levels. Moreover, GlucoTrack is another device developed by U.S.-Israeli company which can monitor blood sugar levels through a combination of ultrasonic, electromagnetic, and thermal waves. Better and more accurate diabetic care in healthcare centers is assisting patients, which is expected to bolster the growth of Israel glucometer market in the forecast period.

Rise in Geriatric Population

Among several chronic diseases, diabetes is the most common disease which is found to be highly prevailing among geriatric population of Israel. According to a survey, it has been observed that in 2018, 11.8% of the total population which accounted for 1,056,300 people were at either 65 years of age or above. Around 55.5% of them were women and rest 44.5 % were men. In the same year, 41% of senior citizens were 75 years of age. Development of risk factors such as physical inactivity and lack of nutrients in diet are the main risk factors which are leading to rise in instances of diabetes among elder people. Growing demand of devices such as glucometer by people to monitor their blood sugar level on regular basis for management of diabetes is likely to propel the growth of glucometer market in Israel during the futuristic period.

Growing Prevalence of Obesity

The accumulation of an excessive amount of body fat can cause diabetes, and the risk of type 2 diabetes increases linearly with an increase in body mass index. Obesity is one of the leading risk factors among Israelis which is reported to be the major reason behind wide spread of diabetes across various regions of the country. According to the report published by Jewish News Syndicate (JNS) in 2023, it was found that 55% of men and 41% of women are overweight. A new study released by Israel’s Central Bureau of Statistics revealed that approximately half of Israelis over the age of 20 are overweight. Moreover, 54 percent of Arabs were found to be overweight, as compared to 46 percent of Jews. Growing prevalence of diabetes among people of Israel due to rise in consumption of unhealthy food is expected to boost the growth of glucometer market in upcoming years.

Israel glucometer market is segmented based on product type, technique, type, distribution channel, end source, company, and region. In terms of product type, the glucometer market is categorized into self glucose monitoring glucometers and continuous glucose monitoring glucometers. Based on, technique, market is divided into invasive and non-invasive. On the basis of type, glucometer market is segmented into wearable and non-wearable. Based on distribution channel, the market is fragmented into hospital pharmacies, retail outlet, online, and others. Based on end user, the glucometer market is segmented into hospitals & clinics, diagnostic centers, home care, and others.

Market Players

Cnoga Medical Ltd., F. Hoffmann-La Roche AG, Medtronic, Inc., Dexcom, Inc., DarioHealth Crop., Tandem Diabetes Care, Inc., Abbott Laboratories, and Dreamed Diabetes Ltd.

Report Scope:

In this report, Israel glucometer market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Israel Glucometer Market, By Product Type:

• Self-Glucose Monitoring Glucometers
• Continuous Glucose Monitoring Glucometers

Israel Glucometer Market, By Technique:

• Invasive
• Non-Invasive

Israel Glucometer Market, By Type:

• Wearable
• Non-Wearable

Israel Glucometer Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Outlet
• Online
• Others

Israel Glucometer Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Home Care
• Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Israel glucometer market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.